Established in 2001, GEROPHARM has evolved into a prominent entity in the Russian pharmaceutical sector and an esteemed expert in the field. As an internationally expanding biotechnology firm, it boasts all insulin blockbusters in its portfolio and is the exclusive producer of Cortexin®. Ranking in the TOP-3 on the Russian insulin market, GEROPHARM conducts full-cycle insulin production, from substance to finished dosage form.